People: Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

14 Oct 2019
Change (% chg)

$0.08 (+0.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Zerhouni,, Elias 

Dr. Elias A. Zerhouni, M.D. is Independent Director of the Company. Dr. Zerhouni has served as President, Global Research & Development, for Sanofi S.A., a global pharmaceutical company, from 2011 to June 2018. From 2008 until 2011, he provided advisory and consulting services to various non-profit and other organizations as Chairman and President of Zerhouni Holdings. From 2002 to 2008, Dr. Zerhouni served as director of the National Institutes of Health, and from 1996 to 2002, he served as Chair of the Russell H. Morgan Department of Radiology and Radiological Sciences, Vice Dean for Research and Executive Vice Dean of the Johns Hopkins School of Medicine. Dr. Zerhouni, a physician, scientist and world-renowned leader in radiology research, is widely viewed as one of the leading authorities in the United States on emerging trends and issues in medicine and medical care. These insights, as well as his deep, technical knowledge of the research and clinical applications of medical technologies, are of considerable importance given Danaher’s strategic focus in the medical technologies markets. Dr. Zerhouni’s government experience also gives him a strong understanding of how government agencies work, and his experience growing up in North Africa, together with the global nature of the issues he faced at NIH and his role at France-based Sanofi, give him a global perspective that is valuable to Danaher.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 200,695
Long-Term Incentive Plans, USD --
All Other, USD 79,121
Fiscal Year Total, USD 279,816

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Steven Rales


Matthew McGrew


Rainer Blair


Daniel Comas


William Daniel


Joakim Weidemanis

As Of  31 Dec 2018